Commercial utilities and future perspective of nanomedicines

The present review aims to describe the commercial utilities and future perspectives of nanomedicines. Nanomedicines are intended to increase precision medicine and decrease the adverse effects on the patient. Nanomedicines are produced, engineered, and industrialized at the cellular, chemical, and...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Rishabha Malviya, Shivkanya Fuloria, Swati Verma, Vetriselvan Subramaniyan, Kathiresan V. Sathasivam, Vinoth Kumarasamy, Darnal Hari Kumar, Shalini Vellasamy, Dhanalekshmi Unnikrishnan Meenakshi, Shikha Yadav, Akanksha Sharma, Neeraj Kumar Fuloria
Formato:	article
Lenguaje:	EN
Publicado:	PeerJ Inc. 2021
Materias:	Nanomedicines Nanotechnology Drug therapy Nanoparticles Disease treatment Medicine R
Acceso en línea:	https://doaj.org/article/ebb0b4777d1f4ea08fcab6414c19d3ac
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ebb0b4777d1f4ea08fcab6414c19d3ac
record_format	dspace
spelling	oai:doaj.org-article:ebb0b4777d1f4ea08fcab6414c19d3ac2021-11-21T15:05:08ZCommercial utilities and future perspective of nanomedicines10.7717/peerj.123922167-8359https://doaj.org/article/ebb0b4777d1f4ea08fcab6414c19d3ac2021-11-01T00:00:00Zhttps://peerj.com/articles/12392.pdfhttps://peerj.com/articles/12392/https://doaj.org/toc/2167-8359The present review aims to describe the commercial utilities and future perspectives of nanomedicines. Nanomedicines are intended to increase precision medicine and decrease the adverse effects on the patient. Nanomedicines are produced, engineered, and industrialized at the cellular, chemical, and macromolecular levels. This study describes the various aspects of nanomedicine such as governing outlooks over high use of nanomedicine, regulatory advancements for nanomedicines, standards, and guidelines for nanomedicines as per Therapeutic Goods Administration (TGA). This review also focuses on the patents and clinical trials based on nanoformulation, along with nanomedicines utilization as drug therapy and their market value. The present study concludes that nanomedicines are of high importance in biomedical and pharmaceutical production and offer better therapeutic effects especially in the case of drugs that possess low aqueous solubility. The factual data presented in this study will assist the researchers and health care professionals in understanding the applications of nanomedicine for better diagnosis and effective treatment of a disease.Rishabha MalviyaShivkanya FuloriaSwati VermaVetriselvan SubramaniyanKathiresan V. SathasivamVinoth KumarasamyDarnal Hari KumarShalini VellasamyDhanalekshmi Unnikrishnan MeenakshiShikha YadavAkanksha SharmaNeeraj Kumar FuloriaPeerJ Inc.articleNanomedicinesNanotechnologyDrug therapyNanoparticlesDisease treatmentMedicineRENPeerJ, Vol 9, p e12392 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Nanomedicines Nanotechnology Drug therapy Nanoparticles Disease treatment Medicine R
spellingShingle	Nanomedicines Nanotechnology Drug therapy Nanoparticles Disease treatment Medicine R Rishabha Malviya Shivkanya Fuloria Swati Verma Vetriselvan Subramaniyan Kathiresan V. Sathasivam Vinoth Kumarasamy Darnal Hari Kumar Shalini Vellasamy Dhanalekshmi Unnikrishnan Meenakshi Shikha Yadav Akanksha Sharma Neeraj Kumar Fuloria Commercial utilities and future perspective of nanomedicines
description	The present review aims to describe the commercial utilities and future perspectives of nanomedicines. Nanomedicines are intended to increase precision medicine and decrease the adverse effects on the patient. Nanomedicines are produced, engineered, and industrialized at the cellular, chemical, and macromolecular levels. This study describes the various aspects of nanomedicine such as governing outlooks over high use of nanomedicine, regulatory advancements for nanomedicines, standards, and guidelines for nanomedicines as per Therapeutic Goods Administration (TGA). This review also focuses on the patents and clinical trials based on nanoformulation, along with nanomedicines utilization as drug therapy and their market value. The present study concludes that nanomedicines are of high importance in biomedical and pharmaceutical production and offer better therapeutic effects especially in the case of drugs that possess low aqueous solubility. The factual data presented in this study will assist the researchers and health care professionals in understanding the applications of nanomedicine for better diagnosis and effective treatment of a disease.
format	article
author	Rishabha Malviya Shivkanya Fuloria Swati Verma Vetriselvan Subramaniyan Kathiresan V. Sathasivam Vinoth Kumarasamy Darnal Hari Kumar Shalini Vellasamy Dhanalekshmi Unnikrishnan Meenakshi Shikha Yadav Akanksha Sharma Neeraj Kumar Fuloria
author_facet	Rishabha Malviya Shivkanya Fuloria Swati Verma Vetriselvan Subramaniyan Kathiresan V. Sathasivam Vinoth Kumarasamy Darnal Hari Kumar Shalini Vellasamy Dhanalekshmi Unnikrishnan Meenakshi Shikha Yadav Akanksha Sharma Neeraj Kumar Fuloria
author_sort	Rishabha Malviya
title	Commercial utilities and future perspective of nanomedicines
title_short	Commercial utilities and future perspective of nanomedicines
title_full	Commercial utilities and future perspective of nanomedicines
title_fullStr	Commercial utilities and future perspective of nanomedicines
title_full_unstemmed	Commercial utilities and future perspective of nanomedicines
title_sort	commercial utilities and future perspective of nanomedicines
publisher	PeerJ Inc.
publishDate	2021
url	https://doaj.org/article/ebb0b4777d1f4ea08fcab6414c19d3ac
work_keys_str_mv	AT rishabhamalviya commercialutilitiesandfutureperspectiveofnanomedicines AT shivkanyafuloria commercialutilitiesandfutureperspectiveofnanomedicines AT swativerma commercialutilitiesandfutureperspectiveofnanomedicines AT vetriselvansubramaniyan commercialutilitiesandfutureperspectiveofnanomedicines AT kathiresanvsathasivam commercialutilitiesandfutureperspectiveofnanomedicines AT vinothkumarasamy commercialutilitiesandfutureperspectiveofnanomedicines AT darnalharikumar commercialutilitiesandfutureperspectiveofnanomedicines AT shalinivellasamy commercialutilitiesandfutureperspectiveofnanomedicines AT dhanalekshmiunnikrishnanmeenakshi commercialutilitiesandfutureperspectiveofnanomedicines AT shikhayadav commercialutilitiesandfutureperspectiveofnanomedicines AT akankshasharma commercialutilitiesandfutureperspectiveofnanomedicines AT neerajkumarfuloria commercialutilitiesandfutureperspectiveofnanomedicines
_version_	1718418859054071808

Commercial utilities and future perspective of nanomedicines

Ejemplares similares